RIPK3 and central nervous system cancer: Analysis of The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases revealed a significant upregulation of RIPK1 and RIPK3 mRNAs in grade II–IV gliomas (G2–G4) compared with normal brain tissue (Fig. 1A).